The Vitamin D Debate: From Universal Supplement to Precision Therapy Review Abstract Vitamin D supplementation has evolved from a simple solution to rickets into one of medicine’s most debated therapeutic interventions. This paper examines the current evidence surrounding vitamin D’s role in health and disease,
Author: Similoluwa Oluwalana
The Return of Old Antibiotics: Are Colistin and Fosfomycin Making a Comeback?
The Return of Old Antibiotics: Are Colistin and Fosfomycin Making a Comeback? Review Abstract The rise of multidrug-resistant bacterial infections has forced clinicians to reconsider older antimicrobial agents previously abandoned due to toxicity concerns. Colistin and fosfomycin, antibiotics discovered decades ago, have experienced renewed clinical
The Great Biomarker Boom: Are We Overdiagnosing Risk or Finally Personalizing Medicine?
The Great Biomarker Boom: Are We Overdiagnosing Risk or Finally Personalizing Medicine? Review Abstract The rapid expansion of biomarker discovery and clinical application has created both unprecedented opportunities and substantial challenges in modern medicine. This analysis examines whether the current biomarker boom represents genuine progress
The Rise of Psychiatry in Oncology: Understanding and Addressing the Mental Health Needs of Cancer Patients
The Rise of Psychiatry in Oncology: Understanding and Addressing the Mental Health Needs of Cancer Patients Review Abstract The field of psycho-oncology has emerged as an essential component of cancer care over the past five decades. This interdisciplinary field addresses the psychological, social, and behavioral
Pain Management Beyond Scores: Function-First Care and Controversy in Chronic Pain
Pain Management Beyond Scores: Function-First Care and Controversy in Chronic Pain Review Abstract Pain assessment in modern medicine has become dominated by numerical rating systems, yet this approach often fails to capture the true impact of chronic pain on patients’ daily lives. This paper examines
The Second Victim Phenomenon: Why Most Anesthesiologists Experience Trauma After Medical Errors
The Second Victim Phenomenon: Why Most Anesthesiologists Experience Trauma After Medical Errors Key Takeaways Understanding the second victim phenomenon is crucial for protecting healthcare professionals’ mental health and maintaining quality patient care. Here are the essential insights every anesthesiologist and healthcare leader should know:
The Microbiome as a Cancer Therapy Lever: Real Clinical Tool or Science Fair?
The Microbiome as a Cancer Therapy Lever: Real Clinical Tool or Science Fair? Abstract The human microbiome has emerged as a potential therapeutic target in oncology, generating considerable interest among researchers and clinicians. This analysis examines current evidence on microbiome-based cancer interventions, evaluating their clinical
Ambulatory Major Surgical Procedures: Establishing Safe Parameters for Same-Day Discharge
Ambulatory Major Surgical Procedures: Establishing Safe Parameters for Same-Day Discharge Abstract Purpose: This review examines the current evidence and safety parameters for performing major surgical procedures in the ambulatory setting with same-day discharge. The analysis focuses on patient selection criteria, procedural limitations, and institutional requirements necessary
Antibiotics for H. pylori: Why First-Line Treatment Fails and What Salvage Regimens Actually Work
Antibiotics for H. pylori: Why First-Line Treatment Fails and What Salvage Regimens Actually Work Key Takeaways pylori treatment has evolved dramatically due to rising antibiotic resistance, requiring physicians to abandon traditional approaches and adopt resistance-resilient strategies from the start. Bismuth quadruple therapy
Alopecia Areata News: New Immune Therapies Challenge Steroid-Only Treatment Approach
Alopecia Areata News: New Immune Therapies Challenge Steroid-Only Treatment Approach Key Takeaways The alopecia areata treatment landscape has transformed dramatically, moving beyond ineffective steroid-only approaches to targeted immune therapies that offer real hope for patients with severe hair loss. Three FDA-approved JAK inhibitors are
